AGENT FOR TREATING HUMAN BODY CONDITIONS ASSOCIATED WITH A DECREASE IN THE LEVEL OF EXPRESSION OF THE PROK 2 GENE AND/OR A DECREASE IN THE AMOUNT OF PROKINETICIN 2 PROTEIN ON THE BASIS OF GENE-THERAPEUTIC SUBSTANCES WITH PROK 2 GENE, METHOD FOR OBTAINING AND USING Russian patent published in 2019 - IPC A61K48/00 A61P9/00

Abstract RU 2677695 C2

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine and relates to an agent for treating conditions of cells of various organs and tissues, as well as the human organs and tissues associated with a decrease in the expression of the PROK 2 gene and/or a decrease in the amount of prokineticin 2 protein, based on gene-therapeutic substances with a PROK 2 gene representing at least one gene-therapeutic substance selected from the group of gene-therapeutic substances, each of which represents a genetic construct based on a vector plasmid comprising the cDNA of PROK 2 gene, with the prokineticin 2 protein coding sequence. Group of inventions also relates to a method for preparation of said agent for treating the human body conditions associated with a decrease in PROK 2 gene expression and/or decrease in the amount of prokineticin 2 protein; a method of using said agent to treat conditions of the human body associated with a decrease in PROK 2 gene expression and/or a decrease in the amount of prokineticin 2 protein.

EFFECT: group of inventions provides the creation of a highly effective agent for treating the human body conditions associated with a decrease in the PROK 2 gene expression and/or a decrease in the amount of prokineticin 2 protein, based on gene-therapy substances with the PROK 2 gene.

5 cl, 18 ex, 20 dwg

Similar patents RU2677695C2

Title	Year	Author	Number
AGENT FOR TREATING HUMAN BODY CONDITIONS ASSOCIATED WITH A DECREASE IN THE LEVEL OF EXPRESSION OF THE PROK 1 GENE AND/OR A DECREASE IN THE AMOUNT OF PROKINETICIN 1 PROTEIN ON THE BASIS OF GENE-THERAPEUTIC SUBSTANCES WITH PROK 1 GENE, METHOD FOR OBTAINING AND USING	2017	Savelieva Natalia Savelieva Natalia	RU2662944C1
AGENT FOR TREATMENT OF HUMAN BODY CONDITIONS ASSOCIATED WITH A DECREASE IN THE LEVEL OF ANG GENE EXPRESSION AND/OR A REDUCTION IN THE AMOUNT AND/OR ACTIVITY OF AN ANGIOGENIN PROTEIN BASED ON GENE THERAPY, A METHOD OF PRODUCTION AND USE	2017	Savelieva Natalia Savelieva Natalia	RU2665771C1
MEANS FOR TREATMENT OF HUMAN BODY STATES RELATED TO DECREASE OF THE CAT GENE EXPRESSION LEVEL AND/OR REDUCTION OF THE CATALYSIS PROTEIN ACTIVITY BASED ON GENE-THERAPEUTIC SUBSTANCES WITH THE CAT GENE, METHOD FOR PRODUCTION AND USE	2017	Savelieva Natalia Sadykova Galina Kadymovna Savelieva Natalia	RU2649814C1
AGENT FOR TREATMENT OF HUMAN BODY STATES RELATED TO P4HA1 GENE REDUCED EXPRESSION AND/OR REDUCED QUANTITY OF PROLYL 4-HYDROXYLASE ALPHA 1 PROTEIN ON BASIS OF GENE-THERAPEUTIC SUBSTANCES WITH P4HA1 GENE, METHOD OF MANUFACTURE AND OPERATION	2017	Krok Igor Semenovich Savelieva Natalia	RU2658428C9
AGENT FOR TREATMENT OF HUMAN ORGANISM STATES RELATED TO DECREASE IN THE LIF GENE EXPRESSION AND/OR DECREASE IN THE AMOUNT OF PROTEIN OF THE FACTOR INHIBITING LEUCEMIA BASED ON GENE-THERAPEUTIC SUBSTANCES WITH LIF GENE, METHOD OF OBTAINING AND USING	2016	Savelieva Natalia Zhuravleva Marina Mikhajlovna Sokolova Anna Nikolaevna Odzhomoko Lyusi Ochiengovna Savelieva Natalia	RU2653487C1
AGENT FOR TREATMENT OF HUMAN ORGANISM STATES RELATED TO DECREASE IN IL-11 GENE EXPRESSION AND/OR DECREASE IN THE AMOUNT OF INTERLEUKIN-11 PROTEIN ON THE BASIS OF GENE-THERAPEUTIC SUBSTANCES WITH IL-11 GENE, THE METHOD OF OBTAINING AND USING	2016	Savelieva Natalia Zhuravleva Marina Mikhajlovna Sokolova Anna Nikolaevna Odzhomoko Lyusi Ochiengovna Savelieva Natalia Sadykova Galina Kadymovna	RU2651048C1
AGENT FOR CORRECTION OF PATHOLOGICAL STATES OF CELLS AND TISSUES AND/OR ORGANS AND HUMAN TISSUE BASED ON COL1A2 GENE, RELATED TO QUANTITATIVE DECREASE OF PROTEIN OF COLLAGEN TYPE I ALPHA 2 CHAIN	2016	Savelieva Natalia Gamolski Anton	RU2649820C2
LINE OF BIOLOGICALLY ACTIVE GENE-THERAPY SUBSTANCES BASED ON CLCA2 GENE FOR CORRECTION OF PATHOLOGICAL STATES OF CELLS OF ORGANS AND TISSUES AND HUMAN ORGANS AND TISSUES, METHOD OF OBTAINING AND USING	2016	Savelieva Natalia Gamolski Anton	RU2652318C2
LINE OF BIOLOGICALLY ACTIVE GENE-THERAPY SUBSTANCES BASED ON TGFB1 GENE FOR CORRECTION OF PATHOLOGICAL STATES OF CELLS OF ORGANS AND TISSUES AND HUMAN ORGANS AND TISSUES, METHOD OF OBTAINING AND USING	2016	Savelieva Natalia Gamolski Anton	RU2652312C2
LINE OF BIOLOGICALLY ACTIVE GENE-THERAPY SUBSTANCES BASED ON TGFBR2 GENE FOR CORRECTION OF PATHOLOGICAL STATES OF CELLS OF ORGANS AND TISSUES AND HUMAN ORGANS AND TISSUES, METHOD OF OBTAINING AND USING	2016	Savelieva Natalia Gamolski Anton	RU2652351C2

RU 2 677 695 C2

Authors

Savelieva Natalia

Dates

2019-01-21—Published

2017-06-19—Filed